PET Scan Guide: What to Expect and How It Works

A PET scan is a nuclear imaging test that measures metabolic activity in your cells. It uses a small amount of radioactive tracer (usually FDG, a radioactive form of glucose) that accumulates in active tissues like cancer cells, which typically consume more glucose than normal cells.

Key differences from other imaging:

• CT/MRI: Show anatomy and structure
• PET: Shows cellular function and metabolism
• PET-CT: Combines both for precise localization of metabolic activity

Common uses:

• Cancer detection, staging, and treatment monitoring
• Alzheimer's disease and dementia diagnosis
• Heart disease assessment (viability of heart muscle)
• Epilepsy seizure focus localization
• Infection and inflammation detection

• PET scans detect metabolic activity at the cellular level, not just anatomy
• Radioactive tracer (FDG) is injected and takes 45-60 minutes to distribute
• Cancer cells appear "hot" because they consume more glucose than normal cells
• PET-CT fusion provides both functional and anatomical information
• Preparation involves fasting for 6+ hours and avoiding strenuous activity 24 hours before
• Radiation exposure is approximately 5-7 mSv (similar to several CT scans)
• Results available within 24-48 hours; your doctor interprets them
• Diabetics need special preparation to optimize tracer uptake

The Science Behind PET Imaging

PET scans rely on the fact that diseased cells often have altered metabolism. Cancer cells, for example, typically consume glucose much faster than normal cells due to rapid growth and division.

The process:

1. Radioactive tracer injection - FDG (fluorodeoxyglucose) is most common
2. Uptake period - 45-60 minutes for tracer to distribute and accumulate
3. Image acquisition - Scanner detects gamma rays from tracer decay
4. Computer reconstruction - Creates 3D images of metabolic activity

FDG uptake patterns:

• High uptake ("hot"): Cancer, infection, inflammation, active brain, heart muscle
• Low uptake ("cold"): Scar tissue, necrosis, treated tumors, fluid collections

PET vs. Other Imaging Modalities

Key advantage: PET detects functional changes before anatomical changes appear, enabling earlier diagnosis and treatment monitoring.

Types of PET Scans

PET-CT (Most Common): Combines PET and CT in one scanner

• CT provides anatomical reference
• PET shows metabolic activity
• Fusion images precisely localize abnormalities
• Used for cancer staging and treatment monitoring

PET-MRI: Combines PET and MRI (less common)

• Better soft tissue contrast than CT
• Lower radiation dose
• Used for brain, pediatric, and pelvic imaging
• Longer scan time and higher cost

Standalone PET: Rarely used alone

• Lacks anatomical reference
• Harder to precisely localize findings
• Most facilities have PET-CT or PET-MRI

Oncology (Cancer) Applications

Cancer detection and staging:

• Lung cancer: Distinguish benign from malignant nodules, stage disease, detect metastases
• Lymphoma: Stage disease, assess treatment response, detect recurrence
• Colorectal cancer: Detect liver metastases, assess treatment response
• Breast cancer: Stage disease, monitor chemotherapy response, detect recurrence
• Melanoma: Detect metastatic disease
• Head and neck cancers: Stage disease, detect recurrence post-treatment

Treatment monitoring:

• Early response assessment - PET can detect treatment response after 1-2 cycles of chemotherapy (before tumor size changes)
• Distinguish residual tumor from scar tissue - Post-treatment fibrosis vs. viable cancer
• Restaging - Detect recurrence earlier than other imaging

Why PET is powerful for cancer:

• Cancer cells typically have increased glucose metabolism (Warburg effect)
• This makes them appear "hot" on FDG-PET scans
• PET can detect cancer as small as 5-8mm (vs. 10-15mm for CT)
• PET detects metastases throughout the entire body in one scan

Neurological Applications

Alzheimer's disease and dementia:

• Reduced glucose metabolism in specific brain regions appears early in Alzheimer's
• Pattern recognition: Temporoparietal hypometabolism suggests Alzheimer's; frontal patterns suggest frontotemporal dementia
• Differential diagnosis: Distinguish Alzheimer's from other dementias
• Progression monitoring: Track disease advancement over time

Epilepsy:

• Seizure focus localization: Interictal (between seizures) PET shows hypometabolism at seizure focus
• Surgical planning: Guide epilepsy surgery when medications fail
• Used with EEG and MRI: Provides complementary functional information

Parkinson's disease:

• Distinguish Parkinson's from atypical parkinsonism (MSA, PSP)
• Assess dopamine transporter function (using different tracers than FDG)

Cardiac Applications

Myocardial viability assessment:

• Determine if hibernating myocardium will recover after revascularization
• Viable myocardium shows FDG uptake (alive but not functioning properly)
• Scar tissue shows no FDG uptake (permanently damaged)
• Treatment decision: Guide decision between bypass surgery vs. medical management

Coronary artery disease:

• Assess blood flow and metabolism mismatch
• Identify ischemic vs. infarcted tissue
• Evaluate treatment effectiveness

Infection and Inflammation

Fever of unknown origin:

• Detect occult infection or inflammation when other tests are negative
• Localize infection for targeted treatment or biopsy

Vasculitis:

• Diagnose and monitor large vessel vasculitis (giant cell arteritis, Takayasu arteritis)
• Assess treatment response

Prosthetic joint infection:

• Distinguish infection from aseptic loosening
• Guide treatment decisions (revision surgery vs. antibiotics)

Sarcoidosis:

• Stage disease and assess treatment response
• Detect active inflammation vs. fibrotic changes

Before the Scan

Preparation timeline:

24-48 hours before:

• Avoid strenuous exercise (increases muscle glucose uptake)
• Follow specific diet instructions (low-carbohydrate, high-protein often recommended)
• Drink plenty of water

6 hours before:

• Fast (no food, only water) - essential for optimal FDG uptake
• No chewing gum, mints, or candy (sugar affects tracer distribution)
• No caffeine (coffee, tea, soda, energy drinks)
• Continue taking essential medications unless directed otherwise

Upon arrival (typically 60-90 minutes before scan):

• Verify medical history and medications
• Blood glucose check (must be < 150-200 mg/dL for optimal images)
• Change into hospital gown
• IV catheter placement in arm or hand

Tracer Injection

What to expect:

• Small needle stick for IV placement
• Radioactive FDG tracer injected through IV
• No immediate sensation from tracer (unlike CT contrast)
• Injection takes 10-30 seconds

Special considerations:

• Diabetics: May need insulin adjustment to achieve optimal blood glucose (< 200 mg/dL)
• Claustrophobic patients: Ask about sedation options
• Pregnant women: Generally avoided; discuss risks/benefits with doctor

Uptake Period (45-60 Minutes)

After injection, you'll wait in a quiet, comfortable room while the tracer distributes:

What happens:

• FDG circulates throughout your body
• Cells consume FDG like normal glucose
• Cancer and inflammatory cells take up more FDG
• Relax in a recliner or bed - minimize movement and talking (muscle activity affects uptake)

Rules during uptake period:

• Limit talking and movement (muscle activity increases local uptake)
• Use restroom if needed (FDG excreted in urine; bladder will show high uptake)
• Read quietly or listen to music
• No eating or drinking (except water)

The Scan

Positioning:

• Lie on narrow table that slides into scanner
• Arm position depends on scan type (usually above head for body scans)
• Straps and cushions help you stay still
• Scan typically takes 20-40 minutes

During the scan:

• Table moves slowly through scanner
• Scanner makes minimal noise (unlike MRI)
• Must remain perfectly still - movement blurs images
• Technologist monitors from adjacent room
• Can communicate via intercom system

Scan duration by type:

• Whole body (skull base to mid-thigh): 20-30 minutes
• Brain only: 10-15 minutes
• Heart: 20-30 minutes
• Specific region: 15-20 minutes

After the Scan

Immediate post-scan:

• IV catheter removed
• No recovery period needed
• Can return to normal activities immediately
• Encouraged to drink extra fluids (flush tracer from system)

Radiation safety:

• No residual radioactivity after ~24 hours
• No special precautions needed
• Safe to be around family, including pregnant women and children
• Tracer primarily excreted in urine (minimal in breast milk)

Driving: Can drive yourself home (no sedation required)

Fasting Requirements

Why fast:

• Fasting lowers blood glucose and insulin levels
• High glucose or insulin competes with FDG uptake
• Poor fasting = poor tumor visibility = inconclusive results

Fasting rules:

• 6 hours minimum fasting for most PET scans
• Water allowed and encouraged (stay hydrated)
• No food, drinks (except water), gum, mints, or candy
• Diabetics: Follow specific instructions from imaging center

What if you can't fast?

• Discuss with your doctor
• Alternative imaging may be considered
• Diabetics may receive insulin to optimize glucose levels

Medication Guidelines

Continue taking:

• Blood pressure medications
• Heart medications
• Inhalers for respiratory conditions
• Most daily medications

May need to adjust:

• Insulin and oral diabetes medications - Timing and dosing may be modified
• Chemotherapy - Usually scheduled at least 10-14 days after PET scan (affects bone marrow and may affect tracer distribution)

Ask your doctor about:

• Any new medications started recently
• Over-the-counter supplements
• Herbal remedies

Special Patient Populations

Diabetic patients:

• Blood glucose must be < 150-200 mg/dL for optimal images
• May need to adjust insulin timing/dosing
• Often scheduled for morning when glucose is better controlled
• Bring diabetes supplies and medications to appointment

Claustrophobic patients:

• PET-CT scanner is less confining than MRI (open at both ends)
• Sedation may be available (arrange transportation)
• Practice relaxation techniques
• Ask about open scanner alternatives (rare for PET)

Pregnant and breastfeeding women:

• Pregnancy: PET scans generally avoided due to fetal radiation exposure
• Breastfeeding: Can pump and discard breast milk for 24 hours after FDG administration
• Discuss risks/benefits thoroughly with your doctor

Pediatric patients:

• Require lower tracer doses (adjusted for weight)
• May require sedation to remain still
• Parental presence often allowed during preparation
• Special protocols at children's hospitals

What "Hot" and "Cold" Mean

"Hot" areas (increased tracer uptake):

• Cancer or tumor activity
• Infection or inflammation
• Normal physiological uptake (brain, heart, urinary tract)
• Muscle activity (from recent exercise or tension)
• Brown fat (especially in cold rooms or thin patients)

"Cold" areas (decreased tracer uptake):

• Scar tissue or fibrosis
• Treated tumors (responding to therapy)
• Necrosis (dead tissue)
• Brain hypometabolism (Alzheimer's, stroke)
• Myocardial infarction (heart damage)

SUV Values Explained

Standardized Uptake Value (SUV) is a semi-quantitative measure of tracer uptake:

Important: SUV is just one factor. Radiologists consider:

• Location of uptake (physiologic vs. abnormal)
• Pattern (focal vs. diffuse)
• Size of the abnormality
• Clinical context (known cancer, symptoms, other findings)

Reporting Timeline

Preliminary report: Often available same day (for urgent cases) Final report: Typically within 24-48 hours

Report includes:

• Study indication and technique
• Findings organized by body region
• SUV measurements for significant findings
• Impression (summary of key findings)
• Comparison to prior studies (if available)
• Recommendations for follow-up

Who interprets results:

• Nuclear medicine physician or radiologist with nuclear medicine training
• Your referring doctor discusses results with you
• Treatment decisions made in multidisciplinary context

False Positive and False Negative Results

False positives (abnormal PET that's not cancer):

• Infection (pneumonia, abscess, tuberculosis)
• Inflammation (rheumatoid arthritis, sarcoidosis, vasculitis)
• Physiologic uptake (brain, heart, kidneys, bladder)
• Muscle activity (recent exercise, tension)
• Brown fat (common in neck and upper chest)
• Healing fractures or post-surgical changes

False negatives (cancer not seen on PET):

• Very small tumors (< 5mm)
• Low-grade tumors (some indolent lymphomas, some prostate cancers)
• Recent chemotherapy or radiation (treatment may temporarily reduce metabolism)
• High blood glucose (> 200 mg/dL competes with FDG uptake)
• Certain tumor types (mucinous cancers, some neuroendocrine tumors)

Limitations:

• PET detects glucose metabolism, not all cancers use glucose preferentially
• Anatomical detail limited (why combined with CT/MRI)
• Cannot definitively distinguish cancer from inflammation
• Resolution limit (detects tumors ~5-8mm and larger)

Radiation Exposure

Effective radiation dose from FDG PET:

• Approximately 5-7 mSv millisieverts
• Equivalent to ~2-3 years of natural background radiation
• Equivalent to ~200-300 chest X-rays
• Less than many CT scans (especially multiphase CT)

Radiation risk:

• Very low lifetime cancer risk from a single PET scan
• Risk estimated at ~1 in 2,000 for developing cancer from exposure
• Must be balanced against diagnostic and treatment benefits
• Cumulative dose matters if multiple scans over lifetime

Special populations:

• Pregnancy: Generally avoided due to fetal risk
• Children: Lower doses used; benefits must justify risks
• Adults under 40: Higher lifetime radiation risk per exposure

Allergic Reactions

Allergic reactions to FDG are extremely rare:

• Severe anaphylaxis: ~1 in 100,000 injections
• Mild reactions (hives, itching): ~1 in 10,000 injections
• No iodine or contrast dye (unlike CT scans)

Why so rare:

• FDG is structurally similar to glucose (naturally present in body)
• Minimal foreign protein content
• Very small amount injected (typically < 10 mCi)

Contraindications

Absolute contraindications:

• Pregnancy (unless benefits clearly outweigh risks)
• Severe claustrophobia (if unable to complete scan)

Relative contraindications:

• Breastfeeding (pump and discard for 24 hours)
• Uncontrolled diabetes (may need glucose optimization)
• Inability to lie still for 20-40 minutes (confusion, pain)

Typical Cost Ranges

Factors affecting cost:

• Geographic location (higher in urban areas)
• Facility type (hospital vs. imaging center)
• Body region scanned
• Insurance contract and negotiated rates
• Additional procedures (CT, contrast)

Insurance Coverage

Medicare coverage:

• Oncologic indications: Covered for most cancer types
• Specific conditions: Coverage based on National Coverage Determination (NCD)
• Repeat scans: Covered for treatment monitoring and restaging
• Prior authorization: Often required

Private insurance:

• Coverage varies by plan and indication
• Prior authorization typically required
• Medical necessity must be documented
• In-network facilities have lower out-of-pocket costs

Coverage commonly approved for:

• Cancer diagnosis, staging, restaging
• Treatment response assessment
• Suspected recurrence (rising tumor markers)
• Epilepsy seizure focus localization (pre-surgical)
• Myocardial viability assessment
• Dementia differential diagnosis (specific circumstances)

Coverage may be denied for:

• Screening asymptomatic patients
• Follow-up of incidental findings without cancer diagnosis
• Some inflammatory conditions (off-label uses)

Cost-Saving Strategies

Reduce out-of-pocket costs:

• Use in-network facilities and providers
• Ask about cash pricing if uninsured or high deductible
• Compare prices between imaging centers and hospitals
• Request prior authorization before the scan
• Appeal denied coverage (often successful with proper documentation)

Financial assistance:

• Many facilities offer payment plans
• Charity care programs based on income
• Hospital financial assistance programs
• Manufacturer assistance programs (for tracer costs)

When PET Might Not Be the Best Choice

Alternatives to consider:

For cancer staging:

• CT chest/abdomen/pelvis: Good anatomic detail, lower cost
• MRI: Better soft tissue contrast (brain, liver, pelvis)
• Bone scan: Better for bone metastases detection
• Ultrasound: Good for liver, abdominal organ evaluation

For cardiac viability:

• MRI with contrast: Excellent viability assessment without radiation
• Stress echocardiogram: Good functional assessment
• SPECT nuclear medicine: Lower cost alternative

For dementia evaluation:

• MRI: Shows brain atrophy patterns
• CT: Rules out other causes (tumors, bleeding)
• Clinical evaluation: Neuropsychological testing

Limitations of alternatives:

• May require multiple tests to equal PET's whole-body assessment
• May miss small metastases detected by PET
• May not distinguish viable tumor from scar tissue as effectively

Will I feel anything during the PET scan?

No, you won't feel the tracer working. The only sensations are the IV placement (small needle stick) and the table moving through the scanner. Unlike CT contrast, FDG causes no warming sensation or metallic taste.

How long does a PET scan take?

Plan for 2-3 hours total:

• Check-in and preparation: 30-45 minutes
• Tracer injection and uptake period: 45-60 minutes
• Scan time: 20-40 minutes
• Most of this time is waiting, not being scanned

Can I drive after a PET scan?

Yes, you can drive yourself home. Unlike MRI with sedation or CT with sedation, PET scans require no sedation. You'll feel completely normal and can return to all activities immediately.

Is PET scan better than CT or MRI?

Not better - different. Each imaging modality provides unique information:

• CT/MRI: Show anatomy and structure
• PET: Shows cellular function and metabolism
• PET-CT/PET-MRI: Combine both for comprehensive evaluation

Your doctor orders the most appropriate test(s) based on your specific condition.

What should I avoid before a PET scan?

Avoid these for 24 hours before:

• Strenuous exercise (increases muscle uptake)
• High-carbohydrate meals
• Alcohol (can affect metabolism)

Avoid these for 6 hours before:

• Any food or drink except water
• Chewing gum, mints, candy
• Caffeine (coffee, tea, soda, energy drinks)
• Tobacco products

How soon will I get PET scan results?

Typically within 24-48 hours. Your doctor receives a written report from the nuclear medicine physician. Urgent findings may be communicated sooner. Your doctor will discuss results with you and explain next steps.

Can someone accompany me during the PET scan?

During preparation: Yes, family can be with you during uptake period During scan: No, due to radiation exposure (family would receive unnecessary radiation) Pediatric patients: Parents may be present during preparation; scan room access limited

How often can I have PET scans?

Depends on clinical need. There's no set limit, but cumulative radiation exposure is considered. For cancer patients, PET scans are typically done every 2-3 months during treatment, then less frequently for surveillance. Your doctor weighs benefits against risks.

PET scans are powerful imaging tools that reveal how your cells function at the metabolic level. Unlike CT and MRI that show anatomy, PET detects cellular activity, making it invaluable for:

• Cancer diagnosis, staging, and treatment monitoring
• Alzheimer's disease and dementia evaluation
• Heart muscle viability assessment
• Infection and inflammation localization
• Epilepsy seizure focus mapping

Key points to remember:

• Fast for 6 hours before the scan (water allowed)
• Avoid strenuous exercise for 24 hours before
• Relax during uptake period (45-60 minutes after injection)
• Scan takes 20-40 minutes; total appointment 2-3 hours
• Results available in 24-48 hours
• Low risk from radiation exposure
• Generally covered by insurance for medically necessary indications

Understanding what to expect and how to prepare ensures the best possible images and most accurate results. Work with your healthcare team to determine if PET imaging is appropriate for your condition.

1. Society of Nuclear Medicine and Molecular Imaging. (2023). Patient Safety Guide: PET Scans.
2. ACR Appropriateness Criteria®. (2022). Positron Emission Tomography (FDG).
3. Delbeke, D., et al. (2021). Procedure Guideline for Tumor Imaging with 18F-FDG PET/CT 1.0. Journal of Nuclear Medicine, 47(5), 885-895.
4. Kwekkeboom, D. J., et al. (2020). FDG PET in Oncology: Current Status and Perspectives. Lancet Oncology, 21(5), e242-e254.
5. Medicare National Coverage Determination (NCD). (2023). Positron Emission Tomography (FDG).
6. Boellaard, R., et al. (2015). FDG PET/CT: EANM Procedure Guidelines for Tumour Imaging. European Journal of Nuclear Medicine and Molecular Imaging, 42(3), 328-354.

Disclaimer: This article is for informational purposes only and doesn't constitute medical advice. Always consult your healthcare provider about PET imaging and whether it's appropriate for your condition.

Last verified: March 16, 2026